Global Fund expands commitment to improve access to HIV drug

April 14 (Reuters) - The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to broaden access to Gilead's HIV prevention drug, with a goal of reaching 3 million people by 2028. Initial deliveries of the drug, lenacapavir, have reached nine African countries, Global Fund said on Tuesday, adding that it would extend the provision of the treatment to 12